Combination of recombinant follicle stimulating hormone with human menopausal gonadotrophin or recombinant luteinizing hormone in a long gonadotrophin-releasing hormone agonist protocol: A retrospective study

Reproductive Medicine and Biology

Volumn 11, Issue 3, 2012, Pages 129-133

  Raju, Gottumukkala Achyuta Rama ^a   Teng, S C ^b   Kavitha, Prathigudupu ^a   Lakshmi, Balabomma Kavitha ^a   Ravikrishna, Cheemakurthi ^a  

^a Krishna IVF Clinic   (India)

^b Merck Pte Ltd   (Singapore)

Author keywords

ICSI; IVF; LH; Ovarian stimulation; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ARTICLE; CELL COUNT; CLINICAL PROTOCOL; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG USE; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84865694934     PISSN: 14455781     EISSN: 14470578     Source Type: Journal    
DOI: 10.1007/s12522-012-0120-2     Document Type: Article

References (16)

1. Humaidan P, Bungum L, Bungam M, Andersen C. Ovarian response and pregnancy outcome related to midfollicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod. 2002;17:2016-21.
2. Lahoud R, Al-Jefout M, Tyler J, Ryan J, Driscoll G. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Hum Reprod. 2006;21:2645-9. (Pubitemid 44542158)
3. Nakagawa K, Ohgi S, Nakashima A, Horikawa T, Sugiyama R, Saito H. The ratio of late-follicular to midfollicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH. J Assist Reprod Genet. 2008;25:359-64.
4. Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe G, Picconeri MG. Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization. Fertil Steril. 2003;79:1037-8. (Pubitemid 36385035)
5. Mochtar MH, van der Veen F, Ziech M, van Wely M Musters A. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2007;18:CD005070.
6. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Fafalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril. 2004;82:1521-6. (Pubitemid 39611376)
7. Veeck L. Atlas of the human oocytes and early conceptus. Baltimore: Williams and Wilkins; 1991. p. 46.
8. Hugues JN, Bstandig B, Bry-Gauillard H, Uzan M, Cedrin- Durnerin I. Comparison of the effectiveness of recombinant and urinary FSH preparations in the achievement of follicular selection in chronic anovulation. Reprod Biomed Online. 2001;3: 195-8.
9. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F-) versus highly purified urinary FSH (Metrodin HP-): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod. 1997;12:2133-9. (Pubitemid 27494016)
10. Hillier SG. Paracrine support of ovarian stimulation. Mol Hum Reprod. 2009;15:843-50.
11. Carone D, Vizziello G, Vitti A, Chiappetta R. Clinical outcomes of ovulation induction in WHO Group I anovulatory women using r-hFSH ? r-hLH in a 2:1 ratio compared to hMG. Hum Reprod. 2010;25:i285-321.
12. Thornton K, Alper MM, Ryley D, Ezcurra D. Outcomes of GnRH antagonist IVF cycles using LH supplementation for COH: FSH/ rhLH vs. FSH/hMG. Fertil Steril. 2006;86:S411.
13. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril. 2002;77: 1170-7. (Pubitemid 34626325)
14. Weghofer A, Munne S, Brannath W, Chen S, Barad D, Cohen J, Gleicher N. The impact of LH-containing gonadotropin stimulation on euploidy rates in preimplantation embryos: Antagonist cycles. Fertil Steril. 2009;92:937-42.
15. Grondahl ML, Borup R, Lee YB, Myrhoj V, Meinertz H, Sorensen S. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin. Fertil Steril. 2009;91: 1820-30.
16. Pezzuto A, Ferrari B, Coppola F, Nardelli GB. LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecol Endocrinol. 2010;26:118-24.